Vascular endothelium and blood proteins

Vascular endothelium and blood proteins refers to the integrated physiological system comprising the inner cellular lining of the blood vessels and the diverse array of proteins circulating within the plasma. The vascular endothelium serves as a critical regulatory interface, controlling vascular tone, permeability, and leukocyte adhesion, while blood proteins such as albumin and coagulation factors maintain osmotic pressure and mediate the clotting cascade [1, 2]. This target is not a single molecular entity but rather a complex environment where numerous pharmacological interactions occur, including drug-protein binding and endothelial receptor modulation [3, 4]. Dysregulation of this system is a hallmark of cardiovascular diseases, systemic inflammation, and coagulopathies [5, 6]. Consequently, many therapeutic strategies aim to stabilize endothelial function or manipulate blood protein activity to treat conditions like hypertension, thrombosis, and sepsis [7, 8]. For example, anticoagulants like heparin interact with both plasma proteins and the endothelial surface to prevent clot formation [5]. Additionally, drugs like statins and VEGF inhibitors exert their effects by modulating endothelial signaling pathways to improve vascular health or inhibit angiogenesis [7, 8]. Understanding the interplay between these components is essential for optimizing drug delivery and minimizing systemic toxicity [9, 10].

Other names

EndotheliumPlasma proteinsBlood-vascular interfaceVascular compartmentBlood pool

Drugs interact with this system through several mechanisms: 1) Reversible binding to plasma proteins (e.g., albumin) to modulate drug distribution and half-life; 2) Activation or inhibition of coagulation factors within the blood; 3) Modulation of endothelial signaling pathways (e.g., eNOS activation, VEGF receptor blockade) to regulate vascular tone and permeability; and 4) Interaction with endothelial surface molecules to prevent leukocyte adhesion and inflammation.